The store will not work correctly when cookies are disabled.
2-(5-(4-carbamimidoylphenyl)furan-2-yl)-1H-indole-5-carboximidamide
ID: ALA4854793
PubChem CID: 164615146
Max Phase: Preclinical
Molecular Formula: C20H17N5O
Molecular Weight: 343.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3cc4cc(C(=N)N)ccc4[nH]3)o2)cc1
Standard InChI: InChI=1S/C20H17N5O/c21-19(22)12-3-1-11(2-4-12)17-7-8-18(26-17)16-10-14-9-13(20(23)24)5-6-15(14)25-16/h1-10,25H,(H3,21,22)(H3,23,24)
Standard InChI Key: ZTQVYHXORMQGLC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
16.8100 -13.4077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3265 -12.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6591 -11.9872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5063 -12.8285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1695 -13.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3451 -13.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0186 -12.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1984 -12.2452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8616 -12.9977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0414 -13.0865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6300 -13.8005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8217 -13.6286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7330 -12.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0189 -12.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2623 -12.7336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7105 -12.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8876 -12.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4720 -11.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6491 -11.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2335 -10.6864 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2335 -12.1187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8876 -10.6864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7105 -10.6864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1262 -11.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9344 -11.5725 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4855 -12.4716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
7 8 1 0
8 9 2 0
6 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
19 21 2 0
18 22 1 0
22 23 2 0
16 24 2 0
23 24 1 0
24 25 1 0
14 25 1 0
13 26 1 0
10 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.39 | Molecular Weight (Monoisotopic): 343.1433 | AlogP: 3.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 128.67 | Molecular Species: BASE | HBA: 3 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.48 | CX Basic pKa: 11.46 | CX LogP: 2.11 | CX LogD: -2.68 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.29 | Np Likeness Score: -0.34 |
References
1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448] |